Calcium is the main essential mineral for building strong bones and sound teeth. Bone remodeling occurs throughout life; new bone is deposited and existing bone is replaced. Peak bone mass development is obtained up to 35 yr of age after which bone resorption is increased. It is therefore imperative that Ca intake meet the recommended dietary allowances not only during the growing period but throughout life. Milk and dairy products are the major food source of Ca in the US diet, supplying about 61% of our intake while other food groups supply the rest. It is almost impossible to supply the recommended dietary allowances of Ca without consuming milk in some form, as most other food groups are low in Ca content. The Ca in dairy products is bioavailable and readily absorbed by the body whereas Ca in other food sources may be less so. Several government surveys have shown that a large proportion of the US population, especially females 11 yr of age and older, have very low Ca intakes that do not meet the recommended dietary allowances for Ca. Recent developments in osteoporosis (porous, brittle, and fragile bones) have indicated that low Ca intake or bioavailability of this mineral is one of the major factors involved in this crippling bone disease. Osteoporosis affects 15 to 20 million middle-aged and elderly persons, especially postmenopausal women who are susceptible to bone fractures. Recent studies on nutrient intake and high blood pressure have reported an inverse relationship between dietary Ca intake and blood pressure levels.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3168/jds.S0022-0302(87)80024-3 | DOI Listing |
J Med Internet Res
January 2025
Centre for Research in Media and Communication, Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia, Selangor, Malaysia.
Background: Cardiovascular disease (CVD) is a major global health issue, with approximately 70% of cases linked to modifiable risk factors. Digital health solutions offer potential for CVD prevention; yet, their effectiveness in covering the full range of prevention strategies is uncertain.
Objective: This study aimed to synthesize current literature on digital solutions for CVD prevention, identify the key components of effective digital interventions, and highlight critical research gaps to inform the development of sustainable strategies for CVD prevention.
Int J Clin Pharm
January 2025
Department of Clinical Pharmacology and Pharmacy, Amsterdam University Medical Centers, Location VUMC, Amsterdam, The Netherlands.
Background: Deprescribing inappropriate cardiovascular and antidiabetic medication has been shown to be feasible and safe. Healthcare providers often perceive the deprescribing of cardiovascular and antidiabetic medication as a challenge and therefore it is still not widely implemented in daily practice.
Aim: The aim was to assess whether training focused on conducting a deprescribing-oriented clinical medication review (CMR) results in a reduction of the inappropriate use of cardiovascular and antidiabetic medicines.
World J Pediatr
January 2025
Institute of Child and Adolescent Health, School of Public Health, Peking University, Beijing, China.
Background: We performed an umbrella review to synthesize evidence on the effects of physical activity (PA) interventions on indicators of physical and psychological health among children and adolescents, including body mass index (BMI), blood pressure (BP), depressive symptoms, and cognitive function.
Methods: PubMed, Embase, Web of Science, and the Cochrane Library were systematically searched from inception through 31 July 2023. We included meta-analyses of randomized controlled trials exploring the effects of PA interventions on BMI, BP, depressive symptoms, or cognitive function in healthy or general children and adolescents.
Curr Cardiol Rep
January 2025
John Ochsner Heart and Vascular Institute, Ochsner Clinical School University of Queensland School of Medicine, New Orleans, LA, USA.
Purpose Of Review: To provide a narrative overview of trends and disparities in the cardiometabolic profiles of U.S. adults by synthesizing findings from nationally representative studies conducted between 1999 and 2020.
View Article and Find Full Text PDFMinerva Cardiol Angiol
January 2025
Department of Neurology, Traditional Chinese Medical Hospital of Huzhou, Huzhou, Zhejiang, China -
Introduction: The current meta-analysis aimed to determine the efficacy of propolis supplementation on hypertension.
Evidence Acquisition: The systematic review and meta-analysis. were undertaken on five online databases to find clinical trials assessing the effects of propolis on systolic blood pressure (SBP) and diastolic blood pressure (DBP) markers up to October 2023.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!